1-2 of 2
Takafumi Okabe
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Abstract A177: Cetuximab resistance associated with dimerization‐independence of oncogenic EGFR mutants

Jeonghee Cho, Liang Chen, Naveen Sangji, Jinyan Du, Takafumi Okabe, Kimio Yonesaka, Joshua M. Francis, Richard J. Flavin, Soyoung Yu, Heidi E. Greulich, Bruce E. Johnson, Michael J. Eck, Pasi A. Jänne, Kwok‐Kin Wong, Matthew Meyerson
Journal: Molecular Cancer Therapeutics
Mol Cancer Ther (2009) 8 (12_Supplement): A177.
https://doi.org/10.1158/1535-7163.TARG-09-A177
Published: 10 December 2009
View article titled, Abstract A177: Cetuximab resistance associated with dimerization‐independence of oncogenic EGFR mutants
Journal Articles

Synergistic antitumor effect of S-1 and the epidermal growth factor receptor inhibitor gefitinib in non-small cell lung cancer cell lines: role of gefitinib-induced down-regulation of thymidylate synthase

Takafumi Okabe, Isamu Okamoto, Sayaka Tsukioka, Junji Uchida, Tsutomu Iwasa, Takeshi Yoshida, Erina Hatashita, Yuki Yamada, Taroh Satoh, Kenji Tamura, Masahiro Fukuoka, Kazuhiko Nakagawa
Journal: Molecular Cancer Therapeutics
Mol Cancer Ther (2008) 7 (3): 599–606.
https://doi.org/10.1158/1535-7163.MCT-07-0567
Published: 17 March 2008
View article titled, Synergistic antitumor effect of S-1 and the epidermal growth factor receptor inhibitor gefitinib in non-small cell lung cancer cell lines: role of gefitinib-induced down-regulation of thymidylate synthase
Open the PDF for Synergistic antitumor effect of S-1 and the epidermal growth factor receptor inhibitor gefitinib in non-small cell lung cancer cell lines: role of gefitinib-induced down-regulation of thymidylate synthase in another window